Clinical Trials Directory

Trials / Unknown

UnknownNCT02334917

Comparison of Fast-Absorbing Sutures for Mohs Surgery

Comparison of Fast-Absorbing Sutures for Mohs Surgery Repair on the Face (ComFAS): a Randomized Controlled Split-scar Study

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is being carried out to assess equivalence of scar outcome for two absorbable sutures used for wound closure on the face in dermatologic surgery: rapidly absorbable polyglactin 910 (VicrylRapide™) and fast-absorbing plain gut (5-0 fast). This is important because absorbable sutures are commonly used in Mohs surgery for epidermal closure, yet there is no evidence indicating if any of the sutures above allow for a better cosmetic outcome (less erythema, edema, and scarring).

Detailed description

Prospective randomized controlled split-scar observer-blinded study. After dermatologic surgery on the face, surgeons have a choice between using non-absorbable or absorbable sutures for skin closure. A dermatologic surgeon favoring absorbable sutures for wound closure will consider many factors in material selection, including ease of manipulation, cost, and absorption time. However, there have been no randomized trials comparing the most important measure: aesthetic/cosmetic outcome. Study endpoint/outcome: use three validated scar assessment tools.

Conditions

Interventions

TypeNameDescription
PROCEDURESurgical wound closure with superficial absorbable suturesDifferent superficial absorbable sutures will be used in the closure of skin wounds after Mohs surgery. No drugs or devices are being compared, only the two different absorbable sutures (Vicryl Rapide and Fast Absorbing Gut).

Timeline

Start date
2015-01-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2015-01-08
Last updated
2015-01-08

Source: ClinicalTrials.gov record NCT02334917. Inclusion in this directory is not an endorsement.